Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 78 entries
Sorted by: Best Match Show Resources per page
LNO3 AND L3 Are Associated With Antiproliferative And Pro-Apoptotic Action In Hepatoma Cells.

Genetics and molecular biology

Zanelatto LC, Silva PB, Sartori D, Panis C, Lepri S, Fátima Âd, Mantovani MS.
PMID: 27303908
Genet Mol Biol. 2016 Apr-Jun;39(2):270-8. doi: 10.1590/1678-4685-GMB-2015-0184.

The identification of antitumoral substances is the focus of intense biomedical research. Two structural analogues of thalidomide, LNO3 and L3, are two synthetic compounds that might possess such antitumor properties. We evaluated the toxicological effects of these substances, including...

Cite
Zanelatto LC, Silva PB, Sartori D, et al. LNO3 AND L3 Are Associated With Antiproliferative And Pro-Apoptotic Action In Hepatoma Cells. Genet Mol Biol. 2016;39(2):270-8doi: 10.1590/1678-4685-GMB-2015-0184.
Zanelatto, L. C., Silva, P. B., Sartori, D., Panis, C., Lepri, S., Fátima, �. �. d., & Mantovani, M. S. (2016). LNO3 AND L3 Are Associated With Antiproliferative And Pro-Apoptotic Action In Hepatoma Cells. Genetics and molecular biology, 39(2), 270-8. https://doi.org/10.1590/1678-4685-GMB-2015-0184
Zanelatto, Leonardo Campos, et al. "LNO3 AND L3 Are Associated With Antiproliferative And Pro-Apoptotic Action In Hepatoma Cells." Genetics and molecular biology vol. 39,2 (2016): 270-8. doi: https://doi.org/10.1590/1678-4685-GMB-2015-0184
Zanelatto LC, Silva PB, Sartori D, Panis C, Lepri S, Fátima Âd, Mantovani MS. LNO3 AND L3 Are Associated With Antiproliferative And Pro-Apoptotic Action In Hepatoma Cells. Genet Mol Biol. 2016 Apr-Jun;39(2):270-8. doi: 10.1590/1678-4685-GMB-2015-0184. PMID: 27303908; PMCID: PMC4910562.
Copy Download .nbib Format: NLM
Fusarium keratitis in Brazil: genotyping, in vitro susceptibilities, and clinical outcomes.

Clinical ophthalmology (Auckland, N.Z.)

Oechsler RA, Yamanaka TM, Bispo PJ, Sartori J, Yu MC, Melo AS, Miller D, Hofling-Lima AL.
PMID: 24039389
Clin Ophthalmol. 2013;7:1693-701. doi: 10.2147/OPTH.S40063. Epub 2013 Aug 29.

BACKGROUND: The purpose of this paper is to describe clinical characteristics and determine correlations between clinical outcomes and antifungal susceptibility among molecularly characterized ocular Fusarium isolates in Brazil.METHODS: Forty-one Fusarium isolates obtained from 41 eyes of 41 patients were...

Cite
Oechsler RA, Yamanaka TM, Bispo PJ, et al. Fusarium keratitis in Brazil: genotyping, in vitro susceptibilities, and clinical outcomes. Clin Ophthalmol. 2013;7:1693-701doi: 10.2147/OPTH.S40063.
Oechsler, R. A., Yamanaka, T. M., Bispo, P. J., Sartori, J., Yu, M. C., Melo, A. S., Miller, D., & Hofling-Lima, A. L. (2013). Fusarium keratitis in Brazil: genotyping, in vitro susceptibilities, and clinical outcomes. Clinical ophthalmology (Auckland, N.Z.), 71693-701. https://doi.org/10.2147/OPTH.S40063
Oechsler, Rafael A, et al. "Fusarium keratitis in Brazil: genotyping, in vitro susceptibilities, and clinical outcomes." Clinical ophthalmology (Auckland, N.Z.) vol. 7 (2013): 1693-701. doi: https://doi.org/10.2147/OPTH.S40063
Oechsler RA, Yamanaka TM, Bispo PJ, Sartori J, Yu MC, Melo AS, Miller D, Hofling-Lima AL. Fusarium keratitis in Brazil: genotyping, in vitro susceptibilities, and clinical outcomes. Clin Ophthalmol. 2013;7:1693-701. doi: 10.2147/OPTH.S40063. Epub 2013 Aug 29. PMID: 24039389; PMCID: PMC3769409.
Copy Download .nbib Format: NLM
Miniaturization for Point-of-Care Analysis: Platform Technology for Almost Every Biomedical Assay.

EJIFCC

Schumacher S, Sartorius D, Ehrentreich-Förster E, Bier FF.
PMID: 27683418
EJIFCC. 2012 Oct 12;23(3):70-5. eCollection 2012 Oct.

Platform technologies for the changing need of diagnostics are one of the main challenges in medical device technology. From one point-of-view the demand for new and more versatile diagnostic is increasing due to a deeper knowledge of biomarkers and...

Cite
Schumacher S, Sartorius D, Ehrentreich-Förster E, et al. Miniaturization for Point-of-Care Analysis: Platform Technology for Almost Every Biomedical Assay. EJIFCC. 2012;23(3):70-5
Schumacher, S., Sartorius, D., Ehrentreich-Förster, E., & Bier, F. F. (2012). Miniaturization for Point-of-Care Analysis: Platform Technology for Almost Every Biomedical Assay. EJIFCC, 23(3), 70-5.
Schumacher, Soeren, et al. "Miniaturization for Point-of-Care Analysis: Platform Technology for Almost Every Biomedical Assay." EJIFCC vol. 23,3 (2012): 70-5.
Schumacher S, Sartorius D, Ehrentreich-Förster E, Bier FF. Miniaturization for Point-of-Care Analysis: Platform Technology for Almost Every Biomedical Assay. EJIFCC. 2012 Oct 12;23(3):70-5. eCollection 2012 Oct. PMID: 27683418; PMCID: PMC4975254.
Copy Download .nbib Format: NLM
Clinical students evaluate present APA approved training programs and make suggestions for changes.

Journal of clinical psychology

Clement PW, Sartoris PC.
PMID: 6031033
J Clin Psychol. 1967 Jan;23(1):57-62. doi: 10.1002/1097-4679(196701)23:1<57::aid-jclp2270230117>3.0.co;2-m.

No abstract available.

Cite
Clement PW, Sartoris PC. Clinical students evaluate present APA approved training programs and make suggestions for changes. J Clin Psychol. 1967;23(1):57-62doi: 10.1002/1097-4679(196701)23:1<57::aid-jclp2270230117>3.0.co;2-m.
Clement, P. W., & Sartoris, P. C. (1967). Clinical students evaluate present APA approved training programs and make suggestions for changes. Journal of clinical psychology, 23(1), 57-62. https://doi.org/10.1002/1097-4679(196701)23:1<57::aid-jclp2270230117>3.0.co;2-m
Clement, P W, and Sartoris, P C. "Clinical students evaluate present APA approved training programs and make suggestions for changes." Journal of clinical psychology vol. 23,1 (1967): 57-62. doi: https://doi.org/10.1002/1097-4679(196701)23:1<57::aid-jclp2270230117>3.0.co;2-m
Clement PW, Sartoris PC. Clinical students evaluate present APA approved training programs and make suggestions for changes. J Clin Psychol. 1967 Jan;23(1):57-62. doi: 10.1002/1097-4679(196701)23:1<57::aid-jclp2270230117>3.0.co;2-m. PMID: 6031033.
Copy Download .nbib Format: NLM
Structure, Single Crystal EPR Spectra, and Exchange Interactions in [Cu(L-proline)(2)](2).5H(2)O and Cu(D,L-proline)(2).2H(2)O.

Inorganic chemistry

Sartoris RP, Ortigoza L, Casado NM, Calvo R, Castellano EE, Piro OE.
PMID: 11671114
Inorg Chem. 1999 Aug 09;38(16):3598-3604. doi: 10.1021/ic9900758.

A new copper(II) compound, [Cu(L-proline)(2)](2).5H(2)O (C(20)Cu(2)H(42)N(4)O(13)) (called compound I) was synthesized and crystallized, and its structure was solved using X-ray methods. It is monoclinic, space group P2(1), with a = 11.187(1) Å, b = 12.172(3) Å, c = 11.661(1)...

Cite
Sartoris RP, Ortigoza L, Casado NM, et al. Structure, Single Crystal EPR Spectra, and Exchange Interactions in [Cu(L-proline)(2)](2).5H(2)O and Cu(D,L-proline)(2).2H(2)O. Inorg Chem. 1999;38(16):3598-3604doi: 10.1021/ic9900758.
Sartoris, R. P., Ortigoza, L., Casado, N. M., Calvo, R., Castellano, E. E., & Piro, O. E. (1999). Structure, Single Crystal EPR Spectra, and Exchange Interactions in [Cu(L-proline)(2)](2).5H(2)O and Cu(D,L-proline)(2).2H(2)O. Inorganic chemistry, 38(16), 3598-3604. https://doi.org/10.1021/ic9900758
Sartoris, R. P., et al. "Structure, Single Crystal EPR Spectra, and Exchange Interactions in [Cu(L-proline)(2)](2).5H(2)O and Cu(D,L-proline)(2).2H(2)O." Inorganic chemistry vol. 38,16 (1999): 3598-3604. doi: https://doi.org/10.1021/ic9900758
Sartoris RP, Ortigoza L, Casado NM, Calvo R, Castellano EE, Piro OE. Structure, Single Crystal EPR Spectra, and Exchange Interactions in [Cu(L-proline)(2)](2).5H(2)O and Cu(D,L-proline)(2).2H(2)O. Inorg Chem. 1999 Aug 09;38(16):3598-3604. doi: 10.1021/ic9900758. PMID: 11671114.
Copy Download .nbib Format: NLM
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies.

Breast care (Basel, Switzerland)

Cazzaniga ME, Verusio C, Ciccarese M, Fumagalli A, Sartori D, Valerio MR, Airoldi M, Moretti G, Ficorella C, Gianni L, Michelotti A, Zambelli A, Febbraro A, Generali D, Pistelli M, Garrone O, Musolino A, Vici P, Maur M, Mentuccia L, La Verde N, Bianchi GV, Artale S, Blasi L, De Laurentiis M, Atzori F, Turletti A, Porpiglia M, Santini D, Fabi A, Gebbia V, Schirone A, Palumbo R, Ferzi A, Frassoldati A, Scavelli C, Clivio L, Giordano M, Donadio M, Biganzoli L, Del Mastro L, Bisagni G, Livi L, Natoli C, Montemurro F, Riccardi F, Romagnoli E, Marchetti P, Torri V, Pronzato P, Mustacchi G.
PMID: 32231495
Breast Care (Basel). 2020 Feb;15(1):30-37. doi: 10.1159/000495469. Epub 2019 Apr 17.

BACKGROUND: Different studies suggest that fulvestrant 500 mg every 28 days (HD-FUL) could be an active treatment in HR+ advanced breast cancer (ABC) patients even treated with aromatase inhibitors in the adjuvant setting. The aim of this analysis is...

Cite
Cazzaniga ME, Verusio C, Ciccarese M, et al. Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies. Breast Care (Basel). 2019;15(1):30-37doi: 10.1159/000495469.
Cazzaniga, M. E., Verusio, C., Ciccarese, M., Fumagalli, A., Sartori, D., Valerio, M. R., Airoldi, M., Moretti, G., Ficorella, C., Gianni, L., Michelotti, A., Zambelli, A., Febbraro, A., Generali, D., Pistelli, M., Garrone, O., Musolino, A., Vici, P., Maur, M., Mentuccia, L., La Verde, N., Bianchi, G. V., Artale, S., Blasi, L., De Laurentiis, M., Atzori, F., Turletti, A., Porpiglia, M., Santini, D., Fabi, A., Gebbia, V., Schirone, A., Palumbo, R., Ferzi, A., Frassoldati, A., Scavelli, C., Clivio, L., Giordano, M., Donadio, M., Biganzoli, L., Del Mastro, L., Bisagni, G., Livi, L., Natoli, C., Montemurro, F., Riccardi, F., Romagnoli, E., Marchetti, P., Torri, V., Pronzato, P., & Mustacchi, G. (2020). Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies. Breast care (Basel, Switzerland), 15(1), 30-37. https://doi.org/10.1159/000495469
Cazzaniga, Marina Elena, et al. "Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies." Breast care (Basel, Switzerland) vol. 15,1 (2020): 30-37. doi: https://doi.org/10.1159/000495469
Cazzaniga ME, Verusio C, Ciccarese M, Fumagalli A, Sartori D, Valerio MR, Airoldi M, Moretti G, Ficorella C, Gianni L, Michelotti A, Zambelli A, Febbraro A, Generali D, Pistelli M, Garrone O, Musolino A, Vici P, Maur M, Mentuccia L, La Verde N, Bianchi GV, Artale S, Blasi L, De Laurentiis M, Atzori F, Turletti A, Porpiglia M, Santini D, Fabi A, Gebbia V, Schirone A, Palumbo R, Ferzi A, Frassoldati A, Scavelli C, Clivio L, Giordano M, Donadio M, Biganzoli L, Del Mastro L, Bisagni G, Livi L, Natoli C, Montemurro F, Riccardi F, Romagnoli E, Marchetti P, Torri V, Pronzato P, Mustacchi G. Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies. Breast Care (Basel). 2020 Feb;15(1):30-37. doi: 10.1159/000495469. Epub 2019 Apr 17. PMID: 32231495; PMCID: PMC7098305.
Copy Download .nbib Format: NLM
An Uncommon Cause of Left Abdominal Pain in a Young Adult.

Gastroenterology

Ronot M, Sartoris R, Sauvanet A.
PMID: 33221407
Gastroenterology. 2021 Jun;160(7):e7-e9. doi: 10.1053/j.gastro.2020.10.054. Epub 2020 Nov 19.

No abstract available.

Cite
Ronot M, Sartoris R, Sauvanet A. An Uncommon Cause of Left Abdominal Pain in a Young Adult. Gastroenterology. 2020;160(7):e7-e9doi: 10.1053/j.gastro.2020.10.054.
Ronot, M., Sartoris, R., & Sauvanet, A. (2021). An Uncommon Cause of Left Abdominal Pain in a Young Adult. Gastroenterology, 160(7), e7-e9. https://doi.org/10.1053/j.gastro.2020.10.054
Ronot, Maxime, et al. "An Uncommon Cause of Left Abdominal Pain in a Young Adult." Gastroenterology vol. 160,7 (2021): e7-e9. doi: https://doi.org/10.1053/j.gastro.2020.10.054
Ronot M, Sartoris R, Sauvanet A. An Uncommon Cause of Left Abdominal Pain in a Young Adult. Gastroenterology. 2021 Jun;160(7):e7-e9. doi: 10.1053/j.gastro.2020.10.054. Epub 2020 Nov 19. PMID: 33221407.
Copy Download .nbib Format: NLM
Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma.

JHEP reports : innovation in hepatology

Souhami A, Sartoris R, Rautou PE, Cauchy F, Bouattour M, Durand F, Giannelli V, Gigante E, Castera L, Valla D, Soubrane O, Vilgrain V, Ronot M.
PMID: 32885156
JHEP Rep. 2020 Jul 17;2(5):100147. doi: 10.1016/j.jhepr.2020.100147. eCollection 2020 Oct.

BACKGROUND & AIMS: We compare the performance of liver surface nodularity (LSN) and liver stiffness measurements (LSM) using transient elastography (TE) for the detection of clinically significant portal hypertension (CSPH) in patients with cirrhosis and hepatocellular carcinoma (HCC).METHODS: All...

Cite
Souhami A, Sartoris R, Rautou PE, et al. Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma. JHEP Rep. 2020;2(5):100147doi: 10.1016/j.jhepr.2020.100147.
Souhami, A., Sartoris, R., Rautou, P. E., Cauchy, F., Bouattour, M., Durand, F., Giannelli, V., Gigante, E., Castera, L., Valla, D., Soubrane, O., Vilgrain, V., & Ronot, M. (2020). Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma. JHEP reports : innovation in hepatology, 2(5), 100147. https://doi.org/10.1016/j.jhepr.2020.100147
Souhami, Alexandra, et al. "Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma." JHEP reports : innovation in hepatology vol. 2,5 (2020): 100147. doi: https://doi.org/10.1016/j.jhepr.2020.100147
Souhami A, Sartoris R, Rautou PE, Cauchy F, Bouattour M, Durand F, Giannelli V, Gigante E, Castera L, Valla D, Soubrane O, Vilgrain V, Ronot M. Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma. JHEP Rep. 2020 Jul 17;2(5):100147. doi: 10.1016/j.jhepr.2020.100147. eCollection 2020 Oct. PMID: 32885156; PMCID: PMC7452899.
Copy Download .nbib Format: NLM
Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus disease.

Journal of hepatology

De Broucker C, Plessier A, Ollivier-Hourmand I, Dharancy S, Bureau C, Cervoni JP, Sogni P, Goria O, Corcos O, Sartoris R, Ronot M, Vilgrain V, de Raucourt E, Zekrini K, Davy H, Durand F, Payancé A, Fidouh-Houhou N, Yazdanpanah Y, Valla D, Rautou PE.
PMID: 34563580
J Hepatol. 2021 Sep 23; doi: 10.1016/j.jhep.2021.09.011. Epub 2021 Sep 23.

BACKGROUND & AIMS: Recent non-malignant non-cirrhotic portal venous system thrombosis (PVT) is a rare condition. Among risk factors for PVT, cytomegalovirus (CMV) disease is usually listed based on a small number of reported cases. The aim of this study...

Cite
De Broucker C, Plessier A, Ollivier-Hourmand I, et al. Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus disease. J Hepatol. 2021;doi: 10.1016/j.jhep.2021.09.011.
De Broucker, C., Plessier, A., Ollivier-Hourmand, I., Dharancy, S., Bureau, C., Cervoni, J. P., Sogni, P., Goria, O., Corcos, O., Sartoris, R., Ronot, M., Vilgrain, V., de Raucourt, E., Zekrini, K., Davy, H., Durand, F., Payancé, A., Fidouh-Houhou, N., Yazdanpanah, Y., Valla, D., & Rautou, P. E. (2021). Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus disease. Journal of hepatology, . https://doi.org/10.1016/j.jhep.2021.09.011
De Broucker, Chloé, et al. "Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus disease." Journal of hepatology vol. (2021). doi: https://doi.org/10.1016/j.jhep.2021.09.011
De Broucker C, Plessier A, Ollivier-Hourmand I, Dharancy S, Bureau C, Cervoni JP, Sogni P, Goria O, Corcos O, Sartoris R, Ronot M, Vilgrain V, de Raucourt E, Zekrini K, Davy H, Durand F, Payancé A, Fidouh-Houhou N, Yazdanpanah Y, Valla D, Rautou PE. Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus disease. J Hepatol. 2021 Sep 23; doi: 10.1016/j.jhep.2021.09.011. Epub 2021 Sep 23. PMID: 34563580.
Copy Download .nbib Format: NLM
[Contribution to the study of esophageal varices].

Minerva otorinolaringologica

SARTORIS A.
PMID: 13746618
Minerva Otorinolaringol. 1961 Jun;11:235-44.

No abstract available.

Cite
SARTORIS A. [Contribution to the study of esophageal varices]. Minerva Otorinolaringol. 1961;11:235-44
SARTORIS, A. (1961). [Contribution to the study of esophageal varices]. Minerva otorinolaringologica, 11235-44.
SARTORIS, A. "[Contribution to the study of esophageal varices]." Minerva otorinolaringologica vol. 11 (1961): 235-44.
SARTORIS A. [Contribution to the study of esophageal varices]. Minerva Otorinolaringol. 1961 Jun;11:235-44. Italian. PMID: 13746618.
Copy Download .nbib Format: NLM
Diagnosing Shoulder Pain.

The Physician and sportsmedicine

Sartoris DJ.
PMID: 29281429
Phys Sportsmed. 1992 Sep;20(9):150-164. doi: 10.1080/00913847.1992.11947489.

In brief When examining an athlete who has acute or chronic shoulder pain, the initial diagnostic imaging method should be plain film radiography. This technique identifies most fractures, dislocations, calcific deposits, and degenerative processes. Other common shoulder disorders may...

Cite
Sartoris DJ. Diagnosing Shoulder Pain. Phys Sportsmed. 1992;20(9):150-164doi: 10.1080/00913847.1992.11947489.
Sartoris, D. J. (1992). Diagnosing Shoulder Pain. The Physician and sportsmedicine, 20(9), 150-164. https://doi.org/10.1080/00913847.1992.11947489
Sartoris, David J. "Diagnosing Shoulder Pain." The Physician and sportsmedicine vol. 20,9 (1992): 150-164. doi: https://doi.org/10.1080/00913847.1992.11947489
Sartoris DJ. Diagnosing Shoulder Pain. Phys Sportsmed. 1992 Sep;20(9):150-164. doi: 10.1080/00913847.1992.11947489. PMID: 29281429.
Copy Download .nbib Format: NLM
The Engagement Between MDSCs and Metastases: Partners in Crime.

Frontiers in oncology

Trovato R, Canè S, Petrova V, Sartoris S, Ugel S, De Sanctis F.
PMID: 32133298
Front Oncol. 2020 Feb 18;10:165. doi: 10.3389/fonc.2020.00165. eCollection 2020.

Tumor metastases represent the major cause of cancer-related mortality, confirming the urgent need to identify key molecular pathways and cell-associated networks during the early phases of the metastatic process to develop new strategies to either prevent or control distal...

Cite
Trovato R, Canè S, Petrova V, et al. The Engagement Between MDSCs and Metastases: Partners in Crime. Front Oncol. 2020;10:165doi: 10.3389/fonc.2020.00165.
Trovato, R., Canè, S., Petrova, V., Sartoris, S., Ugel, S., & De Sanctis, F. (2020). The Engagement Between MDSCs and Metastases: Partners in Crime. Frontiers in oncology, 10165. https://doi.org/10.3389/fonc.2020.00165
Trovato, Rosalinda, et al. "The Engagement Between MDSCs and Metastases: Partners in Crime." Frontiers in oncology vol. 10 (2020): 165. doi: https://doi.org/10.3389/fonc.2020.00165
Trovato R, Canè S, Petrova V, Sartoris S, Ugel S, De Sanctis F. The Engagement Between MDSCs and Metastases: Partners in Crime. Front Oncol. 2020 Feb 18;10:165. doi: 10.3389/fonc.2020.00165. eCollection 2020. PMID: 32133298; PMCID: PMC7040035.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 78 entries